Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer

MASAZUMI SAKAGUCHI, HISAHIRO HOSOGI, SHIGEO HISAMORI, YOSUKE KINJO, SEIICHIRO KANAYA and KAZUTAKA OBAMA
Anticancer Research December 2022, 42 (12) 5937-5944; DOI: https://doi.org/10.21873/anticanres.16103
MASAZUMI SAKAGUCHI
1Department of Surgery, Japanese Red Cross Osaka Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HISAHIRO HOSOGI
1Department of Surgery, Japanese Red Cross Osaka Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hisahoso@kuhp.kyoto-u.ac.jp
SHIGEO HISAMORI
2Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSUKE KINJO
3Department of Gastroenterological Surgery and Oncology, Himeji Medical Center, Himeji, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEIICHIRO KANAYA
1Department of Surgery, Japanese Red Cross Osaka Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUTAKA OBAMA
3Department of Gastroenterological Surgery and Oncology, Himeji Medical Center, Himeji, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 12 5937-5944
DOI 
https://doi.org/10.21873/anticanres.16103
PubMed 
36456133

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 5, 2022
  • Revision received September 23, 2022
  • Accepted October 3, 2022
  • Published online December 1, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. MASAZUMI SAKAGUCHI1,
  2. HISAHIRO HOSOGI1⇑,
  3. SHIGEO HISAMORI2,
  4. YOSUKE KINJO3,
  5. SEIICHIRO KANAYA1 and
  6. KAZUTAKA OBAMA3
  1. 1Department of Surgery, Japanese Red Cross Osaka Hospital, Osaka, Japan;
  2. 2Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan;
  3. 3Department of Gastroenterological Surgery and Oncology, Himeji Medical Center, Himeji, Japan
  1. Correspondence to: Hisahiro Hosogi, Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasaki-cho, Tennoji Ward, Osaka 543-8555, Japan. Tel: +81 667745111, Fax: +81 667745131, e-mail: hisahoso{at}kuhp.kyoto-u.ac.jp
View Full Text

Cited By...

  • 1 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 42 (12)
Anticancer Research
Vol. 42, Issue 12
December 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer
MASAZUMI SAKAGUCHI, HISAHIRO HOSOGI, SHIGEO HISAMORI, YOSUKE KINJO, SEIICHIRO KANAYA, KAZUTAKA OBAMA
Anticancer Research Dec 2022, 42 (12) 5937-5944; DOI: 10.21873/anticanres.16103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer
MASAZUMI SAKAGUCHI, HISAHIRO HOSOGI, SHIGEO HISAMORI, YOSUKE KINJO, SEIICHIRO KANAYA, KAZUTAKA OBAMA
Anticancer Research Dec 2022, 42 (12) 5937-5944; DOI: 10.21873/anticanres.16103
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
  • Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
  • Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • Type 4 gastric cancer
  • splenectomy
  • laparoscopic surgery
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire